Paul Brooke Insider Profile
4 Followers
Paul Brooke, Director at Incyte, holds 261.91K shares in Incyte (Ticker: INCY), holds 0.00 shares in Viropharma (Ticker: VPHM), holds 204.34K shares in WebMD Health (Ticker: WBMD).
Paul Brooke's Trading History
| INCYIncyte | Apr 02, 2020 | Director | Uninformative Buy | 23.95K | $31.68M | |
| VPHMViropharma | Jan 28, 2014 | ― | Uninformative Sell | 6.42M | ― | |
| WBMDWebMD Health | Oct 26, 2009 | ― | Uninformative Buy | 30.00K | $13.58M |
You May Also Like
Paul Brooke insider profile FAQ
What is the percentage of profitable transactions made by Paul Brooke?
The percentage of profitable transactions made by Paul Brooke is 67%.
What is the average return per transaction made by Paul Brooke?
The average return per transaction made by Paul Brooke is 37.40%.
What stocks does Paul Brooke hold?
Paul Brooke holds: INCY, WBMD, VPHM stocks.
What was Paul Brooke’s latest transaction?
Paul Brooke’s latest transaction was an Uninformative Buy of $23.95K.
What was Paul Brooke's most profitable transaction?
Paul Brooke’s most profitable transaction was an Informative Buy of INCY stock on April 30, 2014. The return on the trade was 100.00%.
What is Paul Brooke's role in Incyte?
Paul Brooke's role in Incyte is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
